Researchers make strides in microbiome-based cancer therapies via iron deprivation in the tumor microenvironment

Model of LpIMB19/RHP-induced anti-cancer immunity. Credit: Nature Immunology (2024). DOI: 10.1038/s41590-024-01816-x A team from POSTECH and ImmunoBiome has made a potential breakthrough in the fight against cancer. Their research, published in the May issue of Nature Immunology, explores a dietary-derived bacterial strain, IMB001. This strain induces “nutritional immunity” to boost anti-tumor responses. This discovery sheds light on how microbial therapies work and opens doors for their use in clinical settings. The research, led by Dr. Sin-Hyeog Im, a professor at Pohang University of Science and Technology (POSTECH) and founder & Read More